M. Cecconi
Epidemiology · 2011–2022
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 135 citations into it
- Endocrinology, Diabetes and Metabolism — 26 citations into it
Whom M. Cecconi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Jean-Louis Vincent
- N. Steigbigel
- Mitchell M. Levy
- P. Marik
- X. Monnet
- Derek C. Angus
- V. Marco Ranieri
- R. Hotchkiss
- A. Rhodes
- Djillali Annane
Papers from M. Cecconi's perspective
Ordered by how strongly the researchers M. Cecconi trusts endorse each paper. Same corpus, a different order for every researcher.
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
- Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
- Drotrecogin alfa (activated) in adults with septic shock. (New England Journal of Medicine)
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
- Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. (Journal of the American Medical Association (JAMA))
- Intensive insulin therapy in the medical ICU. (New England Journal of Medicine)
- Acute Respiratory Distress Syndrome
- Mortality after fluid bolus in African children with severe infection. (New England Journal of Medicine)
- Hydrocortisone therapy for patients with septic shock. (New England Journal of Medicine)
Their papers
- A living WHO guideline on drugs for covid-19 (2022) — 784 citations
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy (2020) — 1,804 citations
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure (2020) — 1,738 citations
- Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. (2020) — 2,038 citations
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. (2020) — 4,899 citations
- Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (2020) — 2,417 citations
- Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial (2019) — 739 citations
- Current use of vasopressors in septic shock (2019) — 160 citations
- Sepsis and septic shock. (2018) — 1,076 citations
- Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. (2016) — 627 citations
- Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine (2014) — 1,527 citations
- A Systematic Review and Meta-Analysis on the Use of Preemptive Hemodynamic Intervention to Improve Postoperative Outcomes in Moderate and High-Risk Surgical Patients (2011) — 813 citations